University of Limerick
Browse
- No file added yet -

Modelling and understanding powder flow properties and compactability of selected active pharmaceutical ingredients, excipients and physical mixtures from critical material properties

Download (1.39 MB)
journal contribution
posted on 2017-11-01, 16:09 authored by Zelalem Ayenew Worku, Dinesh Kumar, João Victor Gomes, Yunliang He, Brian Glennon, Kiran A. Ramisetty, Åke C. Rasmuson, Peter O'Connell, Kieran H Gallagher, Trevor Woods, Nalini R Shastri, Anne-Marie Helay
The development of solid dosage forms and manufacturing processes are governed by complex physical properties of the powder and the type of pharmaceutical unit operation the manufacturing processes employs. Suitable powder flow properties and compactability are crucial bulk level properties for tablet manufacturing by direct compression. It is also generally agreed that small scale powder flow measurements can be useful to predict large scale production failure. In this study, predictive multilinear regression models were effectively developed from critical material properties to estimate static powder flow parameters from particle size distribution data for a single component and for binary systems. A multilinear regression model, which was successfully developed for ibuprofen, also efficiently predicted the powder flow properties for a range of batches of two other active pharmaceutical ingredients processed by the same manufacturing route. The particle size distribution also affected the compactability of ibuprofen, and the scope of this work will be extended to the development of predictive multivariate models for compactability, in a similar manner to the approach successfully applied to flow properties.

History

Publication

International Journal of Pharmaceutics;531 (1), pp. 191-204

Publisher

Elsevier

Note

peer-reviewed

Other Funding information

SFI

Rights

This is the author’s version of a work that was accepted for publication in International Journal of Pharmaceutics. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in International Journal of Pharmaceutics, 531 (1), pp. 191-204, https://doi.org/10.1016/j.ijpharm.2017.08.063

Language

English

Usage metrics

    University of Limerick

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC